Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Raymond

Showing results (241-250 of 345) with videos related to

Pageof 35
Sort By:
Anti-Cancer Drugs|April 9, 1999
Recombinant human interleukin-11 is unlikely to stimulate the growth of the most common solid tumorsH Soda, E Raymond, S Sharma, et al.
The American Journal of Cardiology|April 13, 2002
Evidence that angiotensin-converting enzyme inhibitor use diminishes the need for coronary revascularization after stentingStephen G Ellis, A Michael Lincoff, Patrick L Whitlow, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 1999
Molecular detection of telomerase-positive circulating epithelial cells in metastatic breast cancer patientsJ C Soria, L R Gauthier, E Raymond, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|April 21, 2022
Nanoparticle Properties Influence Transendothelial Migration of MonocytesNahal Habibi, Tyler D Brown, Kwasi Adu-Berchie, et al.
Anti-Cancer Drugs|June 23, 1998
Antiproliferative effects of recombinant human bone morphogenetic protein-2 on human tumor colony-forming unitsH Soda, E Raymond, S Sharma, et al.
European Journal of Cancer (Oxford, England : 1990)|July 2, 2002
Multicentre phase II and pharmacokinetic study of RFS2000 (9-nitro-camptothecin) administered orally 5 days a week in patients with glioblastoma multiformeE Raymond, M Campone, R Stupp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2000
Phase I and pharmacokinetic study of the camptothecin analog DX-8951f administered as a 30-minute infusion every 3 weeks in patients with advanced cancerV Boige, E Raymond, S Faivre, et al.
La Revue De Medecine Interne|January 1, 1995
[Extravasation of paclitaxel (Taxol)]E Raymond, S Cartier, C Canuel, et al.
Journal of Materials Chemistry. B|September 5, 2015
Enhancing the protein resistance of silicone via surface-restructuring PEO-silane amphiphiles with variable PEO lengthM A Rufin, J A Gruetzner, M J Hurley, et al.
Insects|September 16, 2020
Tracking Red Palm Mite Damage in the Western Hemisphere Invasion with Landsat Remote Sensing DataJose Carlos Verle Rodrigues, Michael H Cosh, E Raymond Hunt, et al.
Pageof 35

Showing results (241-250 of 345) with videos related to

Sort By:
Pageof 35
Anti-Cancer Drugs|April 9, 1999
Recombinant human interleukin-11 is unlikely to stimulate the growth of the most common solid tumorsH Soda, E Raymond, S Sharma, et al.
The American Journal of Cardiology|April 13, 2002
Evidence that angiotensin-converting enzyme inhibitor use diminishes the need for coronary revascularization after stentingStephen G Ellis, A Michael Lincoff, Patrick L Whitlow, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 1999
Molecular detection of telomerase-positive circulating epithelial cells in metastatic breast cancer patientsJ C Soria, L R Gauthier, E Raymond, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|April 21, 2022
Nanoparticle Properties Influence Transendothelial Migration of MonocytesNahal Habibi, Tyler D Brown, Kwasi Adu-Berchie, et al.
Anti-Cancer Drugs|June 23, 1998
Antiproliferative effects of recombinant human bone morphogenetic protein-2 on human tumor colony-forming unitsH Soda, E Raymond, S Sharma, et al.
European Journal of Cancer (Oxford, England : 1990)|July 2, 2002
Multicentre phase II and pharmacokinetic study of RFS2000 (9-nitro-camptothecin) administered orally 5 days a week in patients with glioblastoma multiformeE Raymond, M Campone, R Stupp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2000
Phase I and pharmacokinetic study of the camptothecin analog DX-8951f administered as a 30-minute infusion every 3 weeks in patients with advanced cancerV Boige, E Raymond, S Faivre, et al.
La Revue De Medecine Interne|January 1, 1995
[Extravasation of paclitaxel (Taxol)]E Raymond, S Cartier, C Canuel, et al.
Journal of Materials Chemistry. B|September 5, 2015
Enhancing the protein resistance of silicone via surface-restructuring PEO-silane amphiphiles with variable PEO lengthM A Rufin, J A Gruetzner, M J Hurley, et al.
Insects|September 16, 2020
Tracking Red Palm Mite Damage in the Western Hemisphere Invasion with Landsat Remote Sensing DataJose Carlos Verle Rodrigues, Michael H Cosh, E Raymond Hunt, et al.
Pageof 35